Published in Sci Rep on July 25, 2014
Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis. Genome Med (2017) 0.75
The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome. Front Immunol (2017) 0.75
The Co-Expression Pattern of p63 and HDAC1: A Potential Way to Disclose Stem Cells in Interfollicular Epidermis. Int J Mol Sci (2017) 0.75
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
STATs and gene regulation. Science (1997) 16.55
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol (2002) 13.10
Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol (2005) 11.57
Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol (2009) 7.95
Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell (1993) 5.86
A road map for those who don't know JAK-STAT. Science (2002) 5.67
Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol (2003) 5.28
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med (2005) 4.92
An entire functional mammary gland may comprise the progeny from a single cell. Development (1998) 4.77
Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science (2010) 4.45
Epidermal stem cells of the skin. Annu Rev Cell Dev Biol (2006) 3.92
Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell (2009) 3.44
Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A (2000) 3.12
Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity (2003) 2.51
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol (2004) 1.96
Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis. Nat Protoc (2010) 1.72
Imiquimod: mode of action. Br J Dermatol (2007) 1.70
Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol (2007) 1.68
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A (2006) 1.59
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist (2008) 1.47
Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol (2005) 1.32
Establishment of 3D organotypic cultures using human neonatal epidermal cells. Nat Protoc (2007) 1.18
Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Leukemia (2006) 1.17
Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol Rev (2009) 1.11
Measuring stem cell frequency in epidermis: a quantitative in vivo functional assay for long-term repopulating cells. Proc Natl Acad Sci U S A (2003) 1.06
Three-dimensional tissue models of normal and diseased skin. Curr Protoc Cell Biol (2008) 1.05
The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med (2008) 1.03
Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03
Imiquimod-induced vitiligo. Dermatol Online J (2007) 1.00
Nuclear factor kappa B signaling initiates early differentiation of neural stem cells. Stem Cells (2012) 0.99
Toll-like receptors: role in dermatological disease. Mediators Inflamm (2010) 0.93
Keratin 17: a critical player in the pathogenesis of psoriasis. Med Res Rev (2013) 0.88
Toll-like receptors and skin. J Eur Acad Dermatol Venereol (2011) 0.84
Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment. Arch Dermatol (2005) 0.82
Imiquimod in the treatment of alopecia universalis. Cutis (2007) 0.77